Head-line is - Ellex iTrackTM global sales were US$6.1 million for the nine month period, up 40% on prior comparative period.
If you break it down further, sales in both the US and Asia (mainly China) were above 50% with strong momentum. Bodes well for the future.
Re the US, this was despite sales from the Soutwest falling which they are seeking to rectify. East coast sales strong off a low base. Also suggesting increasing traction among surgeons.
Note expecting recent investment in sales/marketing head-count to drive continued momentum in Q4.
ROW is ok - but given this is a US first & then Asia story for iTrack I am pleased with the momentum & provides early validation for the investment in sales / mkt opex (for which ELX was punished by the market in the last reporting season).
- Forums
- ASX - By Stock
- Ann: Glaucoma Business FY18Q3 Sales Update
Head-line is - Ellex iTrackTM global sales were US$6.1 million...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $64.06M |
Open | High | Low | Value | Volume |
27.5¢ | 29.0¢ | 27.5¢ | $165.3K | 589.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 74185 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 34267 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 74185 | 0.275 |
3 | 155000 | 0.270 |
6 | 133361 | 0.265 |
4 | 123846 | 0.260 |
2 | 90000 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 34267 | 1 |
0.285 | 10000 | 1 |
0.290 | 102661 | 2 |
0.295 | 100000 | 2 |
0.300 | 295251 | 6 |
Last trade - 16.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
Last
28.0¢ |
  |
Change
0.005 ( 1.82 %) |
|||
Open | High | Low | Volume | ||
27.5¢ | 28.5¢ | 27.5¢ | 195560 | ||
Last updated 15.59pm 30/04/2024 ? |
Featured News
EYE (ASX) Chart |